SUPPORTING MATERIAL MATERIALS AND METHODS

Materials:
Electrophoresis grade acrylamide, ultrapure TRIS base, and ultrapure Na 2 EDTA were purchased from ICN Biomedicals (Costa Mesa, CA). Other chemicals were reagent grade and acquired from either Fisher Scientific (Unionville, ON) or Sigma-Aldrich (Oakville, ON). The Ni 2+ -NTA (nitrilotriacetic acid) agarose beads were purchased from Qiagen (Mississauga, ON). Dodecylphosphocholine (DPC) was obtained from Avanti Polar Lipids (Alabaster, AL). For uniform labeling of protein or peptide for NMR spectroscopy, the stable isotopic compounds 
Construction of MBP-α-peptides:
Three different regions of the gene for murine 18.5 kDa myelin basic protein (MBP) coding for amino acids (A22-K56), (S72-S107), and (S133-S159) (murine MBP sequence numbering, cf., (12;17) , and Figure S1 ) were cloned into the Champion™ pET SUMO (small ubiquitin modifier) Expression System (Invitrogen Life Technologies, Burlington, ON) and were named 1, 2, and 3, respectively. The pET22b rmMBP plasmid containing the complete open reading frame for 18.5 kDa MBP rmC1 (4) was used as template DNA for all polymerase chain reaction (PCR) amplifications. Synthetic oligonucleotides were purchased from Sigma-Aldrich (Oakville, ON). The PCR products coding for peptide regions (A22-K56), (S72-S107), and (S133-S159) of 18.5 kDa murine MBP were amplified using three (3) forward and reverse primer sets: (i) 5'-GCC AGG CAT GGC TTC CTC CC-3', 5'-TCA CTT GCC AGA GCC CCG CT-3' (for the 1-peptide); (ii) 5'-TCG CAG CAC GGC CGG ACC CA-3', 5'-TCA GGA CAG GCC TCT CCC CT-3' (for the 2-peptide); and (iii) 5'-TCG GCT CAC AAG GGA TTC AAG G-3', 5'-TCA GCT GTC TCT TCC TCC CAG C-3' (for the 3-peptide). All PCR reactions were performed using Taq C for 7 min. The PCR products were ligated and TA-cloned directly into the pET SUMO vector, and positive plasmids were confirmed by sequencing (Laboratory Services Division, University of Guelph). Subsequent plasmids coding for SUMO-MBP-α-peptide fusion proteins were transformed into E. coli BL21-CodonPlus (DE3)-RP cells (Stratagene, La Jolla, CA) and were expressed and purified as described below.
Expression and purification of full-length 18.5 kDa recombinant murine MBP (rmC1):
The unmodified 18.5 kDa recombinant murine MBP isoform (rmC1) was expressed in E. coli BL21-CodonPlus(DE3)-RP cells (Stratagene, La Jolla, CA) and purified by nickel-affinity chromatography, followed by ion exchange chromatography to remove minor contaminating material as previously described (4;17) . Protein eluate from the column was dialyzed and lyophilized as previously published (2) . Protein concentration was determined by measuring the absorbance at 280 nm, using the extinction coefficient ε=0.676 Lg (as calculated by SwissProt for protein in 6.0 M guanidium hydrochloride, 0.02 M phosphate buffer, pH 6.5). Purity of the protein preparation was assayed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) with Coomassie blue staining.
Expression and purification of MBP-α-peptides:
Three MBP-α-peptides (1, 2, and 3) fused to His-tagged SUMO at their N-terminus were expressed in E. coli BL21-CodonPlus(DE3)-RP cells (Stratagene, La Jolla, CA). Cells were grown at 37C in 130 mL LB kanamycin (kan) + -chloramphenicol (cam) + (25 μg/mL and 33 μg/mL, respectively) until an A 600nm~1 .0 was reached. Cells were harvested by centrifugation, and the pellet was suspended in 1 L M9 minimal media (kan) + -chloramphenicol (cam) + (25 μg/mL and 33 μg/mL, respectively), and further grown at 37C until A 600nm~0 .7-0.8. The culture was then induced with 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) and grown for a further 4-5 h. Cells were harvested by centrifugation, and the pellet was frozen at -20 o C until used.
The following procedure was applied for each MBP-α-peptide construct. Frozen pellets from the 1 L culture were suspended in 30 mL lysis buffer (phosphate-buffered saline (PBS), pH 8.0, 150 mM NaCl, 1% v/v Tween-20, 10 mM imidazole, 1 mM phenylmethylsulfonylfluoride (PMSF)), homogenized and sonicated on ice six times for 10 s, with 10 s cooling between bursts. Lysates were centrifuged at 25,000 g for 30 min at 4 o C to pellet cell debris, and the supernatants were applied to a column containing a 4 mL bed volume of Ni
2+
-NTA pre-equilibrated with lysis buffer. The column was washed with 40 mL of lysis buffer, followed by another 40 mL of wash buffer (PBS, pH 8.0, 15 mM imidazole), and finally, SUMO-fused MBP-α-peptides were eluted with 25 mL of elution buffer (PBS, pH 8.0, 0.5 M imidazole). Samples from 1.3 mL fractions eluted from these columns were evaluated by discontinuous SDS-PAGE (5% stacking, 14% separating), and pure fractions of each SUMO-fused peptide, separately, were combined and dialyzed against protease buffer (10% glycerol in PBS, pH 8.0), two changes of 2 L each.
Following dialysis, SUMO was removed by Ulp1 protease at a 1:1000 protease to SUMOpeptide w/w ratio at 30 o C for 3 h in the presence of 2 mM dithiothreitol (DTT). Recombinant SUMO Ulp1 protease was expressed from a pET28b plasmid (Novagen, Gibbstown, NJ) containing His-tagged Ulp(403-621), which was a kind gift from Dr. Christopher Lima (SloanKettering Institute, NY) (23) . Digestion mixtures were applied onto three Ni 2+ -NTA (4 mL bed volume) columns pre-equilibrated with protease buffer. The columns were washed with 20 mL of 10 mM imidazole in protease buffer (wash 1), followed by another 20 mL of 15 mM imidazole in the same buffer (wash 2), and bound material was eluted in 20 mL of 0.5 M imidazole in protease buffer. Using Tricine-PAGE (28), MBP-α-peptides were detected in the flow-through and two wash fractions.
The MBP-α-peptides were further purified by reversed-phase high-performance liquid chromatography (HPLC) using a Waters (Mississauga, ON) apparatus with a Symmetry 300 C18, 5 mm, 4.6 x 250 mm column. Acetonitrile constituted the mobile phase, and 0.1% TFA (trifluoroacetic acid) was the ion-pairing agent. Detection was at 214 nm, the flow rate was 1 mL/min, and the column was maintained at 22C. The elution gradient was begun at 80% Solvent A (ddH 2 O with 0.1% TFA) and 20% Solvent B (acetonitrile with 0.1% TFA), and run at a rate of 1% Solvent B/min for 30 min, followed by 5% Solvent B/min for 10 min. Peptides were collected and their purity was assessed using the same method. To confirm the molecular mass, a sample of each MBP-α-peptide was analyzed by matrix-assisted laser desorption/ionization-timeof-flight (MALDI-TOF) mass spectrometry (Protein Analysis Facility, Hospital for Sick Children, Toronto, ON).
The results obtained from these purification procedures are presented in Figure S2 .
Purification of calmodulin:
The expression vector for recombinant Xenopus laevis calmodulin (CaM) was obtained from Dr. M. Ikura (Ontario Cancer Institute, Toronto, ON), and this protein was expressed in E. coli and purified as described (27) .
Purification of actin from chicken muscle: Chicken muscle acetone powder was prepared, and actin was extracted from 8 g of it at a time as described (26) . The purity of actin was checked using MALDI-TOF mass spectrometry, supported by SDS-PAGE, and it was clear that no further purification steps were required. Protein concentration was determined by measuring the absorbance at 280 nm, using the extinction coefficient ε=0.62 Lg . The protein suspended in G-buffer (2 mM TRIS-HCl, pH 8.0, 0.2 mM ATP, 0.2 mM CaCl 2 , and 0.2 mM 2-mercaptoethanol) was aliquoted into 1.5 mL microfuge tubes, flash frozen in liquid nitrogen, and stored at -80C. The pyrene labeling of actin was performed as previously published (16) .
Circular dichroism (CD) spectroscopy:
The experiments were performed using a Jasco J-815 spectropolarimeter (Japan Spectroscopic Co., Tokyo, Japan) using an initial peptide concentration of 0.5 mg/mL in a sample volume of 150 μL in a quartz demountable cuvette with a path length of 0.05 cm. The far-UV CD spectra (180-250 nm) were scanned at a rate of 50 nm/min, with data collection at 1 nm intervals at 30C. The blank was subtracted after each measurement, and the spectra from six successive scans were averaged for each sample. The molar ellipticities were calculated using the MBP-α-peptide concentrations and molar mass. The CD measurements were carried out for each MBP-α-peptide in the following solutions: (i) ddH 2 O; (ii) CD buffer (20 mM Tris-H 2 SO 4 , pH 7.4, 100 mM Na 2 SO 4 ); (iii) 10% TFE in CD buffer; (iv) 20% TFE in CD buffer; (v) 30% TFE in CD buffer; (vi) 40% TFE in CD buffer; (vii) 50% TFE in CD buffer; (viii) 0.5 mM DPC in CD buffer; (ix) 1 mM DPC in CD Buffer; (x) 10 mM DPC in CD buffer; and (xi) 30 mM DPC in CD buffer.
The results obtained from these CD experiments are presented in Figure S3 .
To study the 1-and 3-peptide interactions with Ca 2+ -CaM, CD spectra were collected using a demountable cuvette with a path-length of 0.01 cm in the buffer comprising 20 mM HEPES-KOH, pH 7.4, 100 mM KCl, 5 mM CaCl 2 [cf., (20) ]. For this experiment, we used 0.5 mg/mL peptides (131 M and 176 M, for 1 and 3, respectively) with equimolar amounts of Ca 2+ -CaM.
Isothermal titration calorimetry (ITC):
Experiments were carried out using a VP-ITC instrument (Microcal, Inc., Northampton, MA). Lyophilized apo-calmodulin (apoCaM) was dissolved in 20 mM HEPES-KOH, pH 7.4, 100 mM KCl, 5 mM CaCl 2 , and was extensively dialyzed against the same solution (at least 4 changes). Following the dialysis, the protein was filtered (0.22 μm pore size) and the concentration was estimated from the absorbance at 280 nm = 1.48 (1%, 1 cm). The MBP-α-peptides were dissolved in the same solution prior to experiment at the concentration range of 0.9-1 mM. Samples were degassed in a Thermovac (Northhampton, MA) at 30°C for 10 min. The MBP-α-peptide (either 1, 2, or 3) solution (0.9-1.0 mM) was injected into the sample cell, containing Ca 2+ -CaM (0.07-0.10 mM) in the above solution. Typically, the titrations were carried out with a preliminary injection of 2 μL followed by 28 injections of 10 μL of peptide solution with 300 s spacing between each. All experiments were carried out at 30°C. Before analysis, data from the preliminary 2 μL injection were discarded, and heats of dilution of the peptide into solution of 20 mM HEPES-KOH, pH 7.4, 100 mM KCl, 5 mM CaCl 2 (in the absence of CaM) were subtracted from the "peptide into CaM" titration experiments. The corrected data were integrated and plotted as a function of the molar ratio, and the binding isotherms obtained were fitted to the Origin "one set of sites" model (Origin 5.0, Microcal). To study the effect of Ca 2+ , the same experiments were performed in the Ca 2+ -depleted buffer (20 mM HEPES-KOH, pH 7.4, 100 mM KCl, 8 mM EDTA, 2 mM EGTA).
The thermodynamic parameters derived from these ITC experiments are presented in Table S1 .
Actin polymerization assay: Actin polymerization was followed by measuring an increase in fluorescence intensity of pyrene-labeled actin via an automated microplate fluorescence reader (Polarstar Omega, BMG Laboratory Technologies) using a 367-10 nm filter for excitation and a 407-10 nm filter for emission channels. The stock of 15 μM G-actin was prepared in G-buffer by mixing pyrene-labeled actin with unlabeled actin to a final proportion of 5% label, and 33 μL were added to each well followed by an additional volume of G-buffer calculated to give a final volume of 100 μL after addition of MBP-α-peptides. Stocks of MBP-α-peptides were also prepared in G-buffer at a concentration of 33.75 μM and different volumes were automatically injected across the half area 96-well plate to reach the final volume of 100 μL in each well. Thus, the concentration of MBP-α-peptide ranged from 0.5 μM to 22.5 μM or from 1:0.1 to 1:4.5 [actin]:[1/2/3] molar ratio. In the case of the N-terminal MBP-α-peptide (1), to reach a higher molar ratio, the stock was prepared at a concentration of 60 μM, and different volumes were injected to reach a 1:8 molar ratio of actin to 1-peptide. The plate was mixed for 10 s, and the emission intensity was measured for 30 min at 30C.
In the experiments where the effect of dodecylphosphocholine (DPC) on 1-induced actin polymerization was studied, 33.75 M stock of the peptide was prepared in G-buffer in the presence of 27 mM DPC. To determine the effect of Ca 2+ -CaM on MBP-α-peptide-induced actin polymerization, we used a previously described method (5) . Briefly, to 1.1 nmol of G-actin in 450 μL G-buffer, we added 13.3 nmol of MBP-α-peptide in 20 μL G-buffer, and followed the increase in pyrene fluorescence intensity (excitation at 365 nm and emission at 407 nm) for 30 min. After a plateau was achieved, 13. The results of these analyses are presented in Figure S4 .
Analysis of actin bundling:
To test the ability of 1 to bundle actin in the presence or absence of dodecylphosphocholine (DPC), samples were prepared at a 1:1, 1:4.5, 1:6, and 1:8 actin to peptide molar ratios in a final volume of 600 L. The samples were incubated at 30ºC for 30 min followed by centrifugation at 18,000g for 2 h. Pellets and supernatants were analyzed by SDS-PAGE for the presence of actin and α1-peptide as previously described (2) . The amount of DPC bound to the peptide upon interaction with actin was determined by the Micro-Bartlett phosphorus assay (3). The amount of α1 bound to actin was determined by analysis of the HPLC profile of the resuspended pellets and comparing the integrated areas of peak related to the MBP-α-peptide to a standard curve obtained from running samples with known amount of MBP-α-peptide under the same chromatographic conditions. A demonstration of this actin assembly assay is presented in Figure S5 .
Solution NMR spectroscopy:
For solution NMR spectroscopy of the interaction of the α1-or α3-peptides of 18.5 kDa mMBP with calcium-activated calmodulin (Ca 2+ -CaM), uniformly 13 C, 15 Nlabeled α1-or α3-peptide was prepared as described before, but this time the M9 minimal media was supplemented with -CaM sample at each of the molar ratios. For sequence-specific resonance assignments of the α3-peptide alone in solution, another sample was prepared at molar concentration of 1.6 mM in the same NMR buffer. All spectra were collected on a Bruker Avance III spectrometer operating at a proton Larmor frequency of 600.13 MHz and equipped with a triple resonance cryogenic-operated probe. All resonance assignments were done at 22°C. Sequential connectivities of backbone resonances were established using the standard Bruker suite of 3D heteronuclear experiments: HNCO (9;29), HN(CA)CO (7;14) , HNCACB (24;31), and CBCA(CO)NH (10;24). The acquisition parameters for all spectra are summarized in Table S2 . All spectra were processed using NMRPipe (8) as follows: a cosine-squared window function was applied in all dimensions; then the time domains were zero-filled up to 512 x 512 x 2048 complex points in the F 1 x F 2 x F 3 dimensions, respectively, prior to Fourier transformation. Details of the backbone resonance assignments are given next.
Backbone resonance assignments: All sequence-specific assignments were done within the environment of CARA (Computer-Aided Resonance Assignment) (15) and using a set of inhouse scripts written in LUA (www.lua.org ), and executed using the built-in LUA interpreter. The first script used the HNCO spectrum to pick peaks and create spin-systems automatically, based on Figure S6 shows an example of a fragment of spin-systems after assignment of the α3-peptide. (Figure S7) , and the α1-peptide (Figure S8) , demonstrated peak shifts upon interaction with Ca 2+ -CaM. Since the C-terminal α3-peptide is the primary CaM-target originally predicted (17-19;21) , we analyzed it in detail first. (Solid-state and solution NMR structural studies of the α1-peptide in association with actin and with Ca 2+ -CaM, respectively, are currently underway and will be part of a future publication.) Here, current backbone assignments are provided in Tables S3 and S4 for the α3-peptide alone and complexed with Ca 2+ -CaM, respectively. All measurements were carried out in triplicate at 30ºC. The values shown represent the fitting parameters obtained using the "one set of sites" model. For each variant, "K a " is the association constant, "ΔH" is the change in enthalpy, "ΔS" is the change in entropy, and "n" is the number of ligands bound. Errors correspond to 95% confidence levels in the determination of the parameters. The "-TS" is presented as the mean  standard deviation of at least 3 independent experiments. (22), E-A-E = Echo-AntiEcho (13). Figure S1 : Potential α-helical molecular recognition fragments (A) in the intrinsically disordered 18.5-kDa "classic" murine MBP isoform (B). The amino acid sequence of murine recombinant MBP (rmMBP, or rmC1 for the unmodified form) consists of 168 residues with an additional LEH 6 purification tag at the C-terminus of the protein (panel B); the N-terminal methionine is cleaved post-translationally and is not included in numbering. Three rectangles represent the sequences of polypeptides generated for the purpose of the present study (A22-K56, S72-S107, S133-S159, for 1, 2, and 3, respectively). The insets in panel (A) show strongly amphipathic α-helical regions in the rmC1 sequence suggested also by solution NMR studies (11;17) , inter alia. Arrows show the vertical alignment of hydrophobic moment vector. The helical wheel representations were redrawn from the results generated using the HeliQuest program (http://heliquest.ipmc.cnrs.fr/), and are adapted from reference (11).
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Figure S2: Expression and purification of recombinant murine 18.5 kDa MBP (unmodified rmC1 variant) α-peptides. Three MBP-α-peptides (1, 2, and 3) were expressed using the Champion™ pET SUMO Expression System. Peptides fused with SUMO at their N-terminus were over-expressed and purified using immobilized Ni 2+ -affinity chromatography. The SDS-PAGE analyses presented on the left-hand side of panels (A,C,E) compare the crude lysates "C" and the eluates "E" of three MBP-derived SUMO-peptides (1, 2, and 3, respectively). The right-hand sides of panels (A,C,E) confirm the enzymatic cleavage of SUMO (lane D) from the peptides by Tricine-PAGE analysis. Peptides were further purified by the second round of immobilized Ni 2+ -affinity chromatography followed by an HPLC polishing step. The final purity of the MBP-α-peptides was assessed by analytical HPLC, as shown in panels (B,D,F) for 1, 2, and 3, respectively. -CaM complexes at a 1:1 molar ratio, and for the α3-Ca
2+
-CaM complexes at a 1:1 molar ratio titrated with EDTA-EGTA to a maximum concentration of 5 mM (4 mM EDTA and 1 mM EGTA). All spectra were acquired using identical acquisition parameters and at the same temperature as the HSQC spectrum for the α3-peptide alone as given in Table S1 . 1 
H-
15
N HSQC spectra for the N-terminal α1-peptide, and for the α1-Ca
2+
-CaM complexes at 1:1 and lesser molar ratios (both zoom-in regions in the insets).
